The Patent Finder

CRYSTAL FORMS OF tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS

Anavex Life Sciences Corp.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/IB2016/001181, filed Jul 19, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,413,519CRYSTAL FORMS OF tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 10,966,952Crystal Forms of TETRAHYDRO-N,N-DIMETHYL-2,2-Diphenyl-3-Furanmethanamine Hydrochloride, Processes of Making Such Forms, and Their Pharmaceutical Compositions
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 12,759,986Crystal Forms of Tetrahydro-N, N-DIMETHYL-2, 2-Diphenyl-3-Furanmethanamine, Processes of Making Such Forms, and Their Pharmaceutical Compositions
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 11,661,405Crystal Forms of TETRAHYDRO-N,N-DIMETHYL-2,2-Diphenyl-3-Furanmethanamine Hydrochloride, Processes of Making Such Forms, and Their Pharmaceutical Compositions
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited